DaJiMed supplies high-performance RBC Leukocyte Filters designed for efficient leukocyte reduction in red blood cell concentrates. Available in laboratory and bedside configurations, our RBC leukocyte reduction filter sets serve blood banks, transfusion centers, hospitals, and medical distributors seeking reliable blood filtration products for professional and bulk procurement.
Featuring surface-modified polyester filtration membranes, DaJiMed filters support effective leukocyte removal while maintaining high red blood cell recovery and low hemolysis.
Key Performance Highlights
<0.1 × 10⁶ residual leukocytes per unit on HX models
90% average RBC recovery rate
<0.8% hemolysis rate
≤18 minutes average filtration time
30 mL average filter housing hold-up volume
Performance specifications depend on the selected model and filtration conditions.
DaJiMed offers two main types of RBC leukocyte filter sets to meet different blood processing and transfusion requirements.
Designed for blood banks and laboratory blood processing, these RBC leukocyte filters provide efficient leukocyte reduction during red blood cell component preparation.
Available Models: FSRC450-HE12, FSRC450-HX12
The HE12 model specifies residual leukocytes below 1 × 10⁶ per unit, while the HX12 model specifies below 0.1 × 10⁶ per unit. Both feature hard polycarbonate housings, non-woven polyester membranes, and single-spike configurations.
View Laboratory RBC Filter Sets
DaJiMed bedside RBC leukocyte filters are designed for leukocyte reduction at the point of transfusion, supporting hospitals and healthcare institutions requiring ready-to-use filtration sets.
Available Models: FSRC450-HE10, FSRC450-HE11, FSRC450-HX10, FSRC450-HX11
HE models provide residual leukocyte specifications below 1 × 10⁶ per unit, while HX models provide below 0.1 × 10⁶ per unit. Buyers can also choose between single-spike and dual-spike configurations.
DaJiMed's red blood cell leukocyte filter sets are engineered to balance leukocyte removal, filtration efficiency, and RBC recovery.
| Parameter | Specification |
|---|---|
| Product Type | RBC Leukocyte Reduction Filter Set |
| Applications | Blood Bank, Laboratory, Bedside |
| Residual Leukocytes – HE Series | <1 × 10⁶ /unit |
| Residual Leukocytes – HX Series | <0.1 × 10⁶ /unit |
| Average RBC Recovery | 90% |
| Hemolysis Rate | <0.8% |
| Average Filtration Time | ≤18 minutes |
| Average Housing Hold-up Volume | 30 mL |
| Filter Membrane | Non-woven Polyester Fiber |
| Housing Material | Hard Polycarbonate (PC) |
| Sterilization | EO / Gamma Rays |
| Material Characteristics | Latex-free |
Specifications are based on published DaJiMed product information. Buyers should confirm the applicable model, sterilization method, and technical documentation before procurement.
DaJiMed uses advanced non-ionic membrane surface modification technology to enhance leukocyte adsorption. The optimized polyester fiber structure supports leukocyte capture while allowing red blood cells to pass through the membrane.
With an average RBC recovery rate of 90% and a hemolysis rate below 0.8%, DaJiMed filters are designed to minimize red blood cell loss and damage during filtration.
Integrated, ready-to-use filter configurations support gravity-driven filtration without priming. Their low housing hold-up volume helps reduce residual blood retained inside the filter.
Laboratory and bedside configurations, HE and HX filtration grades, and different spike options allow procurement teams to select filters according to operational needs and technical specifications.
DaJiMed is a China-based manufacturer specializing in blood filtration products, with more than 20 years of experience in leukocyte filtration and over 30 patents.
Our in-house research and development capabilities focus on membrane surface modification technology, leukocyte adsorption performance, and blood compatibility.
Key Advantages for B2B Buyers
Specialized Manufacturing: Dedicated focus on disposable leukocyte reduction filters and related blood filtration products.
Filtration Technology Expertise: Proprietary membrane modification technology developed to improve leukocyte capture.
Product Selection: Laboratory and bedside RBC filter sets with different filtration grades and configurations.
International Industry Experience: Experience working with blood bag manufacturers and medical supply partners in overseas markets.
Technical Communication: Product specifications and relevant documentation can be discussed during supplier evaluation.
Learn more about DaJiMed's filtration technology and company background.
DaJiMed supports professional buyers looking for RBC leukocyte filter sets for ongoing supply, medical distribution, and blood processing projects.
Our products are relevant to:
Blood Banks & Blood Centers: Sourcing RBC leukocyte reduction filter sets for blood component processing.
Medical Distributors & Importers: Evaluating reliable RBC filter products for institutional and regional medical supply channels.
Hospitals & Healthcare Procurement Teams: Selecting bedside RBC filters based on filtration performance and operational requirements.
Blood Bag Manufacturers: Exploring compatible leukocyte filtration products for blood collection and processing systems.
For manufacturers seeking filter components for blood bag integration, DaJiMed also offers Single RBC Leukocyte Filters for OEM Supply.
To help our team understand your purchasing requirements, please provide your preferred filter model, expected order quantity, destination country, intended application, and any required technical or regulatory documentation.
DaJiMed can review your requirements and discuss suitable product configurations and purchasing arrangements.
Laboratory RBC leukocyte filters are intended for blood bank and laboratory processing, while bedside filters are designed for leukocyte reduction at the point of transfusion. DaJiMed provides dedicated configurations for both applications.
The main difference is the specified residual leukocyte level. HE models specify fewer than 1 × 10⁶ residual leukocytes per unit, while HX models specify fewer than 0.1 × 10⁶ per unit. Buyers should select the appropriate model according to their application requirements.
DaJiMed RBC leukocyte filters use non-woven polyester fiber membranes with surface modification technology designed to enhance leukocyte adsorption and support red blood cell recovery.
DaJiMed works with professional medical buyers, distributors, and blood bag manufacturers. Buyers can submit their required models, purchasing quantities, and destination markets to discuss bulk supply arrangements.
Buyers should confirm residual leukocyte specifications, RBC recovery, hemolysis performance, filter configuration, sterilization method, technical documentation, and requirements applicable to their destination market.
Looking for a specialized RBC Leukocyte Filter Supplier for your blood bank, medical distribution business, or blood processing project?
DaJiMed combines advanced filtration technology, specialized manufacturing experience, and multiple RBC filter configurations to support professional procurement requirements.
Contact DaJiMed for Product Specifications & Bulk Pricing
For other blood filtration applications, explore our complete range of Leukocyte Reduction Filter Sets.
2F, No. 132 Buling Road, Huangpu District, Guangzhou, P.R.China
Copyright © Guangzhou DaJi Medical Science and Technology Co., Ltd. All Rights Reserved Sitemap | Powered by 
